Overall, based on the RNA-seq results for melanoma tumor tissues, we concluded that α-KG promotes IFNγ-STAT1/3-CD274 signaling through TET2/3, which in turn improves immune responsiveness and ultimately enhances the therapeutic efficacy of anti-PD1 therapy. This evidence concerns the gene CD274 and melanoma.